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1SUMMARY
The aims of this project were to (a) develop a range of screening and
confirmatory test methods that might be applied to effectively test for the
illicit use of the prohibited nitrofuran antimicrobials, (b) study the
persistence of nitrofuran antimicrobials as bound metabolite residues in
edible tissues and (c) undertake a pan-European survey of the incidence of
nitrofurans in retail pork.
Suitable enzymeimmunoassay (ELISA) screening methods were developed
for metabolites of the two principal nitrofurans (furazolidone and
furaltadone) and these ELISAs are marketed as commercial kit methods. A
mass spectrometry (LC-MS/MS) confirmatory method was developed for the
range of nitrofuran metabolites and this method has been introduced to
laboratories in EU member states and in many non-EU countries. Studies on
the persistence of nitrofurans in animals post-treatment confirmed that the
protein-bound metabolites are the appropriate target analytes for detection
of illicit use of these chemicals in animal production. The pan-European
survey of retail pork identified a problem in at least one EU member state and
demonstrated the effectiveness of the developed methods in identifying
abuse of nitrofuran antimicrobials.
The project made a major contribution to dealing with the food safety issue
posed by nitrofuran antimicrobials by (a) providing testing laboratories with
the analytical tools required for residue testing and (b) providing research
laboratories, regulatory agencies and the food industry with knowledge on the
persistence of these drugs in edible tissues and on their occurrence in meat.
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INTRODUCTION
Use of the nitrofuran antibiotics in food-producing animals was prohibited
within the European Union (Commission Regulation 1442/95) because of
their potentially carcinogenic and mutagenic effects on human health.
Previously, nitrofurans had been widely and effectively used for the
prevention and treatment of gastrointestinal infections caused by Escherichia
coli, Salmonella spp., Mycoplasma spp., Coccidia spp., coliforms and some
other protozoa and as growth promoters in livestock.
The four main nitrofuran antibiotics are furazolidone, furaltadone,
nitrofurantoin and nitrofurazone. Various studies have demonstrated that the
nitrofurans are rapidly metabolised by animals in vivo but that persistent,
tissue-bound metabolites are formed which may be released by acid
hydrolysis in the stomach, giving rise to potentially toxic chemicals.
Most research on the accumulation of parent nitrofurans in food for human
consumption and depletion following withdrawal of medicated feed has
focused on furazolidone, largely because it was the most widely used and the
last of the four major nitrofurans to be banned. A summary of the research on
furazolidone is that the parent compound may only be detected in tissues for
a very short period after withdrawal of treatment but that the tissue-bound
metabolite, AOZ (3-amino-2-oxazolidone), persists for considerable periods
(e.g. at least six weeks) post-withdrawal of furazolidone. This instability of
furazolidone in animal tissues prompted the development of analytical
methods for its metabolite AOZ. However, the decision to monitor
metabolites of furaltadone (3-amino-5-morpholino-methyl-2-oxazolidinone,
AMOZ), nitrofurantoin (1-aminohydantoin, AHD) and nitrofurazone
(semicarbazide, SEM) rather than their parent compounds was based on
limited data suggesting that the parents were as unstable in vivo as was
furazolidone.
Under the European Commission’s Fifth Framework Programme, a project
2
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3entitled “Bound Residues and Nitrofuran Detection” (FoodBRAND 2000-
2004), was established to work on these issues. The project, with seven
partners from the UK (co-ordinator), The Netherlands, Germany, Ireland,
Belgium/Spain, Czech Republic and Hungary undertook the following main
areas of research:
● Developing immunoassay kits and chromatographic (HPLC) methods as
screening tests for bound residues of nitrofurans;
● Developing a mass spectrometry reference (confirmatory) method for
bound residues of nitrofurans;
● Validating the developed methods according to the standards required by
the European Commission;
● Studying the persistence of nitrofurans as bound residues in edible tissues;
● Surveying the occurrence of nitrofuran residues in retail pork;
● Providing the validated methods to testing laboratories.
This report describes the main results for this project and highlights its
important contribution to food safety.
IMMUNOASSAY SCREENING KITS FOR NITROFURANS
Antibody production
Production of suitable antibodies is the key to developing an efficient
enzymeimmunoassay screening method. Antibodies capable of binding
nitrofuran metabolites may be produced by experimental animals (such as
mice and rabbits) when the animals are exposed to the nitrofuran metabolites.
Because the nitrofuran metabolites are relatively small molecules (Figure 1),
they must be linked in an appropriate way to a protein foreign to the
experimental animal; for example, the nitrofuran metabolite of furazolidone,
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4AOZ, might be linked to human serum albumin (HSA). When this
preparation (the “immunogen”) is injected into the experimental animal, an
“immune response” is triggered and antibodies are produced; ideally some of
these antibodies will be highly selective for binding the nitrofuran metabolite.
This binding, or cross-reactivity, is the basis for an enzymeimmunoassay
intended to measure the presence of the nitrofuran metabolite in test samples.
Various approaches to producing antibodies with cross-reactivity to the
nitrofuran metabolites were investigated by the two partners charged with
antibody production, Queen’s University Belfast (polyclonal antibodies) and
Veterinary Research Institute, Brno (monoclonal antibodies). For example,
antibodies might be produced with cross-reactivity to the free nitrofuran
metabolites, AOZ, AMOZ, AHD, SEM, or with cross-reactivity to their
nitrophenyl derivatives NPAOZ, NPAMOZ, NPAHD, NPSEM. Because the
nitrophenyl derivatives are larger than the free nitrofuran metabolites and,
therefore are likely to be better immunogens, and because formation of
nitrophenyl derivatives was a critical step in methods for release and
determination of protein-bound nitrofuran metabolites, antibody production
Figure 1. Structures of nitrofuran metabolites
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concentrated on development of immunogens that would have cross-
reactivity to the nitrophenyl derivatives.
Immunoassay kits
After extensive research, also involving Ashtown Food Research Centre in
antibody evaluation, suitable polyclonal antibodies were developed at
Queen’s University Belfast with sensitive and specific cross-reactivity to the
nitrophenyl derivatives of furazolidone (NPAOZ) and furaltadone
(NPAMOZ). The commercial partner in the project, R-Biopharm, used these
antibodies to develop two enzymeimmunoassay kits for determination of
AOZ and AMOZ in a broad range of foods including meat, liver, fish,
shellfish, egg and milk. These commercial kits provide testing laboratories and
the food industry with the capacity to carry out screening assays on food
products for some of the principal nitrofurans, furazolidone and furaltadone
(Table 1).
Research at the Veterinary Research Institute, Brno on developing antibodies
with cross-reactivity to the free nitrofuran metabolites did not produce
5
Table 1.  Performance of RIDASCREEN® ELISA kits for nitrofuran metabolites
Test Kits: AOZ (Art. No. R3701)
AMOZ (Art. No. R3711)
Time required for assay of 10 samples: 1 working day (plus overnight incubation)
Cross-reaction with other nitrofurans: < 0.05%
Recovery of residue from test samples: 70 - 90 %
Detection limit: 0.2 ppb
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6suitable antibodies within the timescale of the project. Subsequently, using
immunogens developed in Belfast, the Brno laboratory successfully prepared
a monoclonal antibody with cross-reactivity to derivatised AOZ. An
immunoassay was developed using this antibody that gave a detection
capability of 0.4 µg/kg in a range of food types.
EXTRACTION METHOD FOR NITROFURANS
Ashtown Food Research Centre undertook to develop a suitable extraction
method for determination of nitrofuran metabolites by enzymeimmunoassay.
The traditional approach to analysis for tissue-bound residues of nitrofurans,
previously developed at Ashtown Food Research Centre (E. Horne, A
Cadogan, M. O’Keeffe and L.A.P. Hoogenboom, Analyst, (1996), 121, 1463),
involved extensive pre-washing of the tissue sample, acid hydrolysis and
derivatisation with nitrobenzaldehyde, solvent extraction of the derivatised
metabolites, clean-up by solvent washing and determination by high
performance liquid chromatography. The aim in this project was to develop a
much simpler procedure that might be automated and would be suitable for
rapid sample screening by immunoassay.
The approach adopted was direct acid hydrolysis/derivatisation followed by
solid phase extraction (SPE) to isolate the nitrophenyl derivatives both from
the tissue matrix and from interfering nitrobenzaldehyde derivatising agent.
Following acid hydrolysis/derivatisation, centrifugation and filtration were
used to prepare the samples for SPE
but this procedure was time-
consuming and gave low recovery of
the nitrofuran metabolite. An
alternative protease digestion step was
used prior to acid
hydrolysis/derivatisation and this
allowed for direct application of the
1 2
Figure 2. Effect of protease digestion
on sample clarification
Sample 1 – no protease digestion
Sample 2 – protease digestion
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7filtrate to the SPE cartridge (Figure 2). For the SPE purification, a
combination of two cartridges were used - (a) a mixed-mode polymeric
sorbent with reversed phase and anion exchange properties (Oasis™ MAX)
was used to trap over 90% of the surplus nitrobenzaldehyde while selectively
recovering the derivatised nitrofuran metabolites, and (b) a further reversed
phase sorbent (Oasis™ HLB) was used, with modification of pH, to remove in
excess of 99% of the nitrobenzaldehyde and matrix interferences. The
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Figure 3 (a). Chromatogram of tissue extract containing NPAOZ after
Oasis™ MAX clean-up
Figure 3 (b). Chromatogram of tissue extract containing NPAOZ after
Oasis™ MAX plus Oasis™ HLB clean-up
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8effective purification of the tissue extract using this dual-SPE approach is
shown in Figures 3(a) and 3(b) while results obtained for AOZ determination
are shown in Table 2.
CHROMATOGRAPHIC METHODS FOR NITROFURANS
High performance liquid chromatography (HPLC)
Based on the method for determination of nitrofuran metabolites by enzyme
immunoassay, a method suitable for determination by HPLC was developed
at Ashtown Food Research Centre. Because HPLC methods are generally not
as sensitive as immunoassays, a larger sample size of 5g was used for the
HPLC assay (instead of the 1g sample size used for the immunoassays). The
Table 2. Data on performance of dual-SPE method for Furazolidone
Sample AOZ determined (mean ± SD); n = 9
AOZ (µg/kg) Recovery (%)
Pig liver, fortified (400 mg/kg) 316 ± 119 79 ± 29.8
Pig liver, incurred 223 ± 24.9
Figure 4. Extraction and dual-SPE procedure, using Oasis™ MAX and HLB
cartridges, for HPLC determination of nitrofuran metabolites
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9traditional method, involving pre-washing of the tissue sample, acid
hydrolysis/derivatisation and solvent extraction, was used together with the
dual-SPE clean-up described previously (Figure 4).
This method was developed based on the furazolidone metabolite, AOZ, and
validated with fortified and incurred samples (Table 3). In addition, an inter-
laboratory comparison between the HPLC method at Ashtown Food Research
Centre and an LC-MS/MS method at the RIKILT laboratory demonstrated
agreement within 10% for three different liver samples. The liver samples
were from pigs (15 kg) treated with furazolidone (300 mg/day) for 5 days and
following withdrawal periods of 10 days (pig 1), 3 days (pig 2) and 0 days (pig
3).
Table 3.  Performance of HPLC method for Furazolidone in porcine liver
(a) Validation of the HPLC method
Sample n AOZ determined (µg/kg) Mean recovery
(%)
____________________ ______________
Mean ± SD RSD (%)
Control 6 None detected
Control + 5 µg/kg 6 4.2  ± 0.80 19.2 83.5
Control + 25 µg/kg 5 22.5  ± 3.67 16.3 89.8
Incurred sample 5 170   ± 30.4 17.9
(b) Comparison between HPLC and LC-MS/MS determination of AOZ
Sample AOZ (µg/kg)
HPLC LC-MS/MS
Incurred pig liver, No. 1 217 203
Incurred pig liver, No. 2 750 684
Incurred pig liver, No. 3 990 1084
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The applicability of the developed method
as a multi-residue method for nitrofuran
metabolites was tested. While recovery of
AOZ and SEM was 90%, recovery of
AMOZ and AHD was approximately 50%,
indicating the need for modification of the
SPE procedure for a multi-residue
nitrofuran metabolite method. Further
development of this method was not
undertaken because the LC-MS/MS
method developed in the project (see
below) has become the method of choice
for chromatographic tests for nitrofurans.
Mass spectrometry (LC-MS/MS)
method
The RIKILT laboratory was primarily responsible for development of an LC-
MS/MS method that would be suitable as a reference (confirmatory) method
for nitrofuran metabolites. This method was developed (Figure 5) and
validated (Table 4) and made available, through training courses, to the
Community and National Reference Laboratories within the EU and to Third
Countries. It was used also for the pan-European Retail Pork Survey in the
project (see below).
PERSISTENCE OF NITROFURANS IN TISSUES
Since the methods developed in the project are all directed at determination
of bound nitrofuran metabolites, it was important to demonstrate that these
marker residues are appropriate for checking for abuse of nitrofurans. The
Queen’s University Belfast, together with partners at RIKILT,Wageningen and
the National Food Investigation Institute, Budapest, studied the persistence of
the four nitrofurans in edible tissues (muscle, liver, kidney) of pigs for a period
Figure 5. Analytical procedure
based on LC-MS/MS for tissue-
bound nitrofuran metabolites
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Table 4. Performance characteristics for LC-MS/MS method for nitrofurans
(tissue samples fortified with nitrofuran metabolites at 1 mg/kg)
Parameter AOZ AMOZ AHD SEM
(a) Pig muscle
Accuracy (%) 92 94 103 97
Repeatability 0.21 0.21 0.24 0.18
Within-laboratory Reproducibility 0.24 0.22 0.24 0.22
Limit of Detection (µg/kg) 0.15 0.20 0.10 0.10
Limit of Quantitation (µg/kg) 0.19 0.70 0.50 0.30
(a) Pig liver
Accuracy (%) 102 105 105 108
Repeatability 0.15 0.28 0.28 0.19
Within-laboratory Reproducibility 0.21 0.27 0.30 0.22
Limit of Detection (µg/kg) 0.20 0.10 0.10 0.30
Limit of Quantitation (µg/kg) 0.60 0.30 0.60 0.60
of six weeks after treatment. Four groups of 18 pigs each received therapeutic
doses of the four nitrofuran drugs for 10 days and then 3 animals from each
treatment were slaughtered at weekly intervals during the subsequent period.
At zero withdrawal time, no residues of nitrofurantoin parent drug were
determined in any tissue and low levels (< 1µg/kg) of furazolidone and
furaltadone parent drugs were determined in only one of three samples of
muscle and liver respectively. Residues of nitrofurazone parent drug (4-22
µg/kg) were determined in all three muscle tissue samples at zero withdrawal
R9144 Nitrofurans  15/1/07  1:54 pm  Page 11
time but not in liver or kidney. After one week withdrawal, no residues of the
nitrofuran parent drugs were determined in any tissue samples. These results
confirmed the instability of the nitrofuran parent drugs and their unsuitability
as marker residues for abuse of nitrofurans in animal production.
In contrast to the nitrofuran parent drugs, residues of the four tissue-bound
metabolites, AOZ (furazolidone), AMOZ (furaltadone), AHD
(nitrofurantoin) and SEM (nitrofurazone), occurred at high concentrations in
all tissues at zero withdrawal time; 900-5000 µg/kg in liver, 700-4000 µg/kg
in kidney and 250-2000 µg/kg in muscle. Residues of these metabolites were
measurable for a period of six weeks post-treatment in all tissues and residue
concentrations in the three tissues after six weeks withdrawal were 10-40
µg/kg AOZ, 10-60 µg/kg AMOZ, 4-7 µg/kg AHD and 40-250 µg/kg SEM.
Figure 6 gives data for the depletion half-lives for the tissue-bound nitrofuran
metabolites; the depletion half-life for a chemical is the time taken for the
residue concentration in tissue to decrease by half.
12
Figure 6. Depletion half-lives for tissue-bound nitrofuran metabolites in pigs
fed nitrofuran-medicated feed (400 mg/kg) for 10 days followed by a six-
week withdrawal period.
Muscle
Liver 
Kidney
Nitrofuran metabolite
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RETAIL PORK SURVEY FOR NITROFURANS
A major component of the research project was to undertake a comprehensive
multi-country survey on the incidence of nitrofurans in meat. Because
previous usage of nitrofurans had been associated with intensive animal
production systems, such as that used for pigs, a pan-European survey of pork
was planned. Using pork purchased through retail outlets would provide a
profile of the potential exposure of the European citizen to these prohibited
substances.
Retail sampling
Retail sampling was designed and co-ordinated by Verbruikers Unie Test-
Aankoop S.V. using consumer associations in 12 countries of the EU –
Belgium (including Luxembourg), France, Austria, Germany, The
Netherlands, Spain, Portugal, Italy, Sweden, Denmark, Greece and Ireland.
Samples were also received from the United Kingdom and the Czech
Republic (using retail purchase of samples) and from Hungary, through
official sampling at pig slaughter houses.
Sampling was undertaken over the period April to September 2002 with
sampling in each country normally occurring over a four-week period. Retail
samples, 100 samples from each country, were purchased from a variety of
outlets such as supermarkets, independent pork butchers, chains of butcher
outlets and public markets and included organic meat where available.
Sampling was required to take account of geographical distribution and
market share for each type of outlet.
Each sample consisted of a 100g portion of pork chop or pork fillet, free of
bone. The sample was sub-divided into two equivalent samples of
approximately 50 g each (“A” and “B”) which were stored in separately
labelled plastic bags. The samples were frozen at -18°C for at least 24 h prior
to transport to Ashtown Food Research Centre.
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Sample analysis
The “A” samples were individually assigned random numbers, removed from
the original bag and repackaged in bags labeled only with the random
numbers; the “B” samples were retained in their original packaging in frozen
storage. One-third (500) of the “A” samples were provided to each of three
laboratories for residue extraction; National Food Investigation Institute,
Budapest, Queen’s University Belfast, Ashtown Food Research Centre,
Dublin. A common procedure was used at each laboratory to develop
composite samples (3 to 1) for analysis. The composite samples were
extracted in each laboratory according to a common procedure for LC-
MS/MS analysis based on the procedure outlined in Figure 5. The dried
sample extracts were shipped on ice overnight to RIKILT, Wageningen for
residue determination by LC-MS/MS.
Assessment of laboratory performance
Prior to undertaking the sample preparation for the retail survey samples, the
three laboratories carried out pre-testing of their procedures. Using a
common source of residue-free pork muscle, each laboratory prepared a series
of 15 samples fortified with nitrofurans and these were used to determine
individual laboratory performance. Table 5 gives data on limits of detection
and quantification and on accuracy for each of the three laboratories. These
results indicated that the three laboratories might undertake sample
preparation for LC-MS/MS analysis with satisfactory and broadly comparable
performance in terms of LOD, LOQ and accuracy. Limits of quantification
for the assay were 0.1 µg/kg AOZ and AMOZ, 0.2 µg/kg SEM and 0.5 µg/kg
AHD.
Results of retail survey
No residues of nitrofuran metabolites were detected in 485 composite
samples, representing 1455 individual samples. Positive responses for one or
more of the nitrofuran metabolites were determined in 15 composite samples.
14
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Table 5. Performance characteristics (limits of detection, limits of
quantification, accuracy) calculated for samples prepared by three laboratories.
Limit of detection (µg/kg) Limit of quantification (µg/kg)
Nitrofuran Laboratory Number Laboratory Number
metabolite ___________________ __________________
1 2 3 1 2 3
AOZ 0.03 0.04 0.03 0.11 0.08 0.06
AMOZ 0.03 0.03 0.02 0.07 0.06 0.04
AHD 0.07 0.04 0.04 0.49 0.43 0.37
SEM 0.09 0.07 0.06 0.18 0.15 0.16
Accuracy (Mean, µg/kg ± CV, %)
[based on extraction of nitrofuran metabolites from pork 
samples fortified at 0.5 µg/kg (n = 6)]
Laboratory Number
1 2 3
AOZ 0.56 ± 12.6 0.50 ± 3.7 0.51 ± 16.3
AMOZ 0.49 ± 2.8 0.48 ± 6.6 0.47 ± 20.0
AHD 0.47 ± 5.1 0.53 ± 8.8 0.55 ± 15.4
SEM 0.48 ± 7.7 0.48 ± 8.3 0.55 ± 21.8
The individual “A” samples (n = 45) from which the composite samples
showing positive results were prepared were extracted by the three
laboratories and analysed by LC-MS/MS. In each case, one individual sample
(total 15) from each composite gave a positive response for a nitrofuran
metabolite. The “B” samples corresponding to the 15 positive “A”samples,
together with five other randomly-chosen “B” samples to act as negative
controls, were identified and analysed in duplicate, with all steps of sample
preparation and LC-MS/MS determination being performed by the RIKILT
laboratory. As had been decided prior to the initiation of the testing
programme, the results for the “B” samples were taken as the confirmed results
R9144 Nitrofurans  15/1/07  1:54 pm  Page 15
16
for the presence of nitrofuran metabolites in retail samples of pork. From
analysis of the “B” samples, 12 samples of pork were determined to contain
measurable levels of nitrofuran metabolites (Table 6). 10 samples contained
AMOZ at concentrations between 0.2 and 1.0 µg/kg; nine of these pork
samples were purchased in Portugal and one sample was purchased in Italy.
Two samples contained AOZ at concentrations of 0.3 and 3.0 µg/kg; these
pork samples were purchased in Portugal and Greece respectively.
The results for the survey show a confirmed incidence for measurable
nitrofuran metabolites in 12 of 1500 samples of pork purchased in retail
outlets in 15 European countries. This represents an incidence of 0.8%
overall. However, the incidence varied between 1% and 10% for the three
countries in which the nitrofuran-positive pork was purchased. The
occurrence of a high incidence of nitrofuran-positive pork, primarily
furaltadone (AMOZ), in Portugal was not surprising given the reported
occurrence of furaltadone in chicken in Portugal in 2003 [European Union
website (http://europa.eu.int/comm/food/fs/rc/scfcah/ah_aw/rap09_en.pdf)].
Following on the notification of the results of this pork survey to the
Portuguese authorities in March 2003, additional steps to eliminate the use of
nitrofurans in animal production in Portugal have been taken. The results of
the retail survey demonstrate the usefulness of the FoodBRAND project in
identifying problems with nitrofurans in meat and in supporting EU member
states and non-EU countries with effective analytical methodology to
monitor the illicit use of nitrofurans in meat production.
CONCLUSIONS
● A range of screening (enzymeimmunoassays) and confirmatory (mass
spectrometry) methods have been developed and made available to test for
nitrofurans in food samples. Testing laboratories in Europe and in Third
Countries were assisted with development of state-of-the-art testing
capacity for nitrofurans from the FoodBRAND project. These
developments were very timely, coinciding with the emergence of a global
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Table 6. Results for testing of composite and individual A samples and
individual B samples of pork from the European Retail Survey.
Samples
Nitrofuran      _____________________________________________ Confirmed Country
metabolite Composite Aa Individual A Individual B result of purchase
(µg/kg) (µg/kg) Sample Codeb (µg/kg)c
AMOZ 0.20 0.25 RA01 0.28 Positive Portugal
AHD 0.15 27.2 RA02 ND Negative
AOZ 0.90 2.6 RA03 3.0 Positive Greece
AMOZ 0.10 0.33 RA04 0.40 Positive Portugal
RA05 ND (Control)
AMOZ 0.45 0.45 RA06 0.55 Positive Portugal
AMOZ 0.10 0.25 RA07 0.30 Positive Portugal
AMOZ 0.20 0.25 RA08 0.25 Positive Portugal
AOZ 0.10 0.35 RA09 ND Negative
AMOZ 0.10 0.30 RA10 0.35 Positive Portugal
RA11 ND (Control)
AMOZ 0.10 0.25 RA12 0.20 Positive Portugal
AMOZ 0.10 0.30 RA13 0.25 Positive Portugal
AMOZ 0.10 0.35 RA14 0.30 Positive Portugal
RA15 ND (Control)
AHD -d 0.40 RA16 ND Negative
AOZ 0.15 0.30 RA17 0.33 Positive Portugal
RA18 ND (Control)
RA19 ND (Control)
AMOZ 0.25 0.90 RA20 1.05 Positive Italy
a Total of 500 samples, representing 1500 “A” samples; 485 samples showing no residues of
nitrofurans
b A random numbering system, RA01-RA20, was applied to the 15 “B” samples for investigation
and to 5 additional samples used as negative controls (RA05, RA11, RA15, RA18, RA19).
c ND - no detectable residue of nitrofuran metabolites.
d The composite sample showed an apparent positive result for AOZ, but only a low concentration
of AHD was found on subsequent analysis in one of the individual “A” samples.
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problem relating to widespread nitrofuran use in 2002-03. Nitrofuran
metabolites were determined in poultry and aquaculture products from
many countries, including Thailand, Vietnam, Brazil and Portugal. In the
two years since 2003, over 150 Rapid Alerts (RASFF) were issued by the
European Commission concerning findings of nitrofuran metabolites in
food products from 29 countries. Trade restrictions were implemented and
positive clearance of shipments of imported food were required. The test
methods developed within the FoodBRAND project provided the
necessary analytical capability. In 2004 alone, over 2500 immunoassay test
kits developed in the project were used for commercial testing. Ashtown
Food Research Centre established the LC-MS/MS method and have
applied it for testing samples taken in the National Residue Testing Plan
(DAF).
● The information on persistence of nitrofurans in edible tissues as tissue-
bound nitrofuran metabolites confirmed (a) the potential presence of these
drugs for extended periods after use on animals and (b) that tissue-bound
metabolites are the appropriate target residues to check for abuse of these
drugs in animal production.
● The pan-European survey on retail pork identified a significant abuse
situation in one member state (Portugal) and potential abuse in some other
countries. This served to alert the EU to a food safety problem;
subsequently, there have been incidences of nitrofuran abuse identified in a
number of other member states. The pan-European survey on retail pork
also served as an excellent model for a large-scale multi-national food safety
investigation, including the logistics for sampling, laboratory assessment
and multi-laboratory performance of testing to an appropriately high
standard.
RECOMMENDATIONS TO INDUSTRY
This research investigated a particular food safety problem relating to residues
of the prohibited antimicrobials, nitrofurans, in meat and fish products. The
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project developed test kits for two of the major nitrofurans, furazolidone and
furaltadone, and confirmatory test methods by mass spectrometry for the range
of nitrofurans. The project also confirmed that the most suitable target analytes
for residue testing are tissue-bound nitrofuran metabolites and identified a
European and world-wide problem with abuse of nitrofuran drugs in animal
production.
Industry is required, both under the self-monitoring provisions in EC Directive
96/23 and under HACCP schemes, to ensure that animals for slaughter and
animal tissues and fish to be used in food production do not contain any trace
of prohibited substances, such as nitrofurans. As part of such due diligence,
testing of foods for residues may be required. The commercial test kits and the
confirmatory methods developed in this project provide a range of residue
testing procedures that may be used by the food industry and by regulatory
agencies to ensure that food products are free of nitrofuran residues.
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